top of page

A public-private partnership will fund clinical trials of vaccines that could prevent cancer recurrence

Oct 29
1 min read

WSJ Pro 

March 17, 2026 11:15 am ET


Momentum is building for therapeutic cancer vaccines. Following the global think tank convened by the Cancer Vaccine Coalition and AACR, HHS, through the National Cancer Institute, is advancing a proposed $200 million public-private partnership to fund clinical trials of vaccines that could help prevent cancer recurrence. "Beating Cancer Daily" Podcast Host and CVC board member, Saranne Rothberg, and CVC Founder Kristen Dahlgren among the patient advocates and survivors working to bring this promising science closer to patients.




 
 
 

Comments


bottom of page